Nuvation Bio Inc.
NUVB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13 | $5 | $3 | $6 |
| % Growth | 171.5% | 56.7% | -46% | – |
| Cost of Goods Sold | $3 | $3 | $2 | $4 |
| Gross Profit | $10 | $2 | $1 | $1 |
| % Margin | 74.5% | 46.7% | 32.1% | 26.2% |
| R&D Expenses | $29 | $27 | $25 | $29 |
| G&A Expenses | $37 | $0 | $0 | $0 |
| SG&A Expenses | $37 | $38 | $35 | $26 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $66 | $66 | $60 | $55 |
| Operating Income | -$56 | -$64 | -$59 | -$54 |
| % Margin | -430.1% | -1,315.7% | -1,913.2% | -944.5% |
| Other Income/Exp. Net | $1 | $5 | $6 | $4 |
| Pre-Tax Income | -$56 | -$59 | -$53 | -$49 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$56 | -$59 | -$53 | -$49 |
| % Margin | -425.2% | -1,220.9% | -1,726.2% | -865.8% |
| EPS | -0.16 | -0.17 | -0.16 | -0.15 |
| % Growth | 5.9% | -6.3% | -6.7% | – |
| EPS Diluted | -0.16 | -0.17 | -0.16 | -0.15 |
| Weighted Avg Shares Out | 342 | 341 | 339 | 337 |
| Weighted Avg Shares Out Dil | 342 | 341 | 339 | 337 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $5 | $5 | $6 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$55 | -$58 | -$53 | -$49 |
| % Margin | -417.4% | -1,204.8% | -1,714.4% | -860.4% |